StockData
Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) stock

MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.40−0.14 (-1.86%)

Close on Nov 16, 2026Market cap $1.92BP/E –Yield –

Maravai LifeSciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Maravai LifeSciences

Maravai LifeSciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Maravai LifeSciences figures

See a number that looks wrong?